Castleark Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Castleark Management's TXG Position: Q3 2026 in Review
Castleark Management opened a new position in 10x Genomics (TXG) in Q3 2026: 73,500 shares worth $6.64M. The stake represents 0.17% of the portfolio and ranks #127 among its holdings. This is a return to the name: Castleark Management previously reported a position in TXG as recently as Q2 2023.
Castleark Management first reported a position in TXG in Q2 2023 and has held it in 2 quarters since. 488 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Castleark Management held 73,500 shares of 10x Genomics worth $6.64M as of Q3 2026.
- 10x Genomics was a new Castleark Management position in Q3 2026.
- 10x Genomics made up 0.17% of Castleark Management's portfolio in Q3 2026, its #127 holding.
- Castleark Management first reported a position in 10x Genomics in Q2 2023 and has held it in 2 quarters since.
- 488 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Castleark Management's 13F filing for Q3 2026, filed 16 Nov 2026.